IL1B and systemic-onset juvenile idiopathic arthritis: In RA patients, however, IL-1 antagonists display relatively modest effects, although they are very effective in the treatment of systemic-onset juvenile idiopathic arthritis, of adult-onset Still's disease, and of several autoinflammatory disorders [13].